Physician profile
Dan G Mcbride
NPI 1255339768
$3,580.86
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,633 · 2020: $297 · 2021: $186 · 2022: $1,449 · 2023: $15.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15.69.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,340.64 | 2022 | |
| Neotract INC. | $1,189.99 | 2019-2020 | |
| Boston Scientific Corporation | $305.61 | 2019 | |
| Astellas Pharma US INC | $182.83 | 2019-2022 | |
| 180 Medical, INC. | $108.68 | 2019-2022 | |
| Comsort, INC | $100.00 | 2019 | |
| Antares Pharma, INC. | $57.14 | 2019-2023 | Xyosted, Tlando, Nocdurna |
| Myovant Sciences INC. | $47.30 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $39.65 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $37.34 | 2022 | |
| Urogen Pharma, INC. | $33.85 | 2021 | |
| Pfizer INC. | $33.16 | 2021 | |
| Abbvie INC. | $31.87 | 2019 | |
| Blue Earth Diagnostics | $25.90 | 2019-2021 | |
| Accord Healthcare, INC. | $18.40 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acerus Pharmaceuticals Corporation | $16.07 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $12.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dan Mcbride listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.